MAPKs were also reported to be classical signaling pathways mediated by TRAF6 in tumor progression, ultimately leading to the activation of NF‐κB and AP‐110, 35; however, whether TRAF6 performs some other regulatory mechanisms that can contribute to chemoresistance is still worth being explored. Here, TRAF6 is linked to neoplasm.